Francesco Portaluppi
Francesco Portaluppi
American Association for Medical Chronobiology and Chronotherapeutics, Austin, Texas (USA)
Verified email at unife.it
TitleCited byYear
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial
L Hansson, A Zanchetti, SG Carruthers, B Dahlöf, D Elmfeldt, S Julius, ...
The Lancet 351 (9118), 1755-1762, 1998
77381998
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial
S Julius, SE Kjeldsen, M Weber, HR Brunner, S Ekman, L Hansson, ...
The Lancet 363 (9426), 2022-2031, 2004
32932004
Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre …
THE EUROPA INVESTIGATORS, including F Portaluppi
Lancet 362 (9386), 782-788, 2003
25072003
Ethics and methods for biological rhythm research on animals and human beings
F Portaluppi, MH Smolensky, Y Touitou
Chronobiology international 27 (9-10), 1911-1929, 2010
8192010
Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis. Principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a …
A Zanchetti, MG Bond, M Hennig, A Neiss, G Mancia, C Dal Palù, ...
Circulation 106 (19), 2422-2427, 2002
7472002
Relation between blood pressure variability and carotid artery damage in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis (ELSA)
G Mancia, G Parati, M Hennig, B Flatau, S Omboni, F Glavina, B Costa, ...
Journal of hypertension 19 (11), 1981-1989, 2001
4122001
Ethical principles and standards for the conduct of human and animal biological rhythm research
Y Touitou, F Portaluppi, MH Smolensky, L Rensing
Chronobiology international 21 (1), 161-170, 2004
3562004
Ethical and methodological standards for laboratory and medical biological rhythm research
F Portaluppi, Y Touitou, MH Smolensky
Chronobiology international 25 (6), 999-1016, 2008
3202008
Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis
A Zanchetti, MG Bond, M Hennig, A Neiss, G Mancia, CD Palù, L Hansson, ...
Journal of hypertension 16 (7), 949-961, 1998
3201998
Chronobiological patterns of acute aortic dissection
RH Mehta, R Manfredini, F Hassan, U Sechtem, E Bossone, JK Oh, ...
Circulation 106 (9), 1110-1115, 2002
2582002
Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial
RE Schmieder, SE Kjeldsen, S Julius, GT McInnes, A Zanchetti, TA Hua, ...
Journal of hypertension 26 (3), 403-411, 2008
2512008
ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: PERTINENT
C Ceconi, KM Fox, WJ Remme, ML Simoons, M Bertrand, G Parrinello, ...
Cardiovascular research 73 (1), 237-246, 2007
2312007
Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study
A Zanchetti, L Hansson, B Dahlöf, D Elmfeldt, S Kjeldsen, R Kolloch, ...
Journal of hypertension 19 (6), 1149-1159, 2001
2302001
Undiagnosed sleep-disordered breathing among male nondippers with essential hypertension
F Portaluppi, F Provini, P Cortelli, G Plazzi, N Bertozzi, R Manfredini, ...
Journal of hypertension 15 (11), 1227-1233, 1997
2231997
Loss of nocturnal decline of blood pressure in hypertension due to chronic renal failure
F Portaluppi, L Montanari, M Massari, V Di Chiara, M Capanna
American journal of hypertension 4 (1 Pt 1), 20-26, 1991
2221991
Circadian variation of blood pressure: the basis for the chronotherapy of hypertension
RC Hermida, DE Ayala, F Portaluppi
Advanced drug delivery reviews 59 (9-10), 904-922, 2007
2062007
Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trial
SE Kjeldsen, S Julius, G Mancia, GT McInnes, T Hua, MA Weber, A Coca, ...
Journal of hypertension 24 (7), 1405-1412, 2006
2022006
The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial of cardiovascular events in hypertension. Rationale and design
J Mann, S Julius, THE VALUE INVESTIGATORS, including F Portaluppi
Blood Pressure 7 (3), 176-183, 1998
2001998
Benefits and risks of more intensive blood pressure lowering in hypertensive patients of the HOT study with different risk profiles: does a J-shaped curve exist in smokers?
A Zanchetti, L Hansson, D Clement, D Elmfeldt, S Julius, T Rosenthal, ...
Journal of hypertension 21 (4), 797-804, 2003
1872003
Baseline reproducibility of B-mode ultrasonic measurement of carotid artery intima-media thickness: the European Lacidipine Study on Atherosclerosis (ELSA)
R Tang, M Hennig, B Thomasson, R Scherz, R Ravinetto, R Catalini, ...
Journal of hypertension 18 (2), 197-201, 2000
1832000
The system can't perform the operation now. Try again later.
Articles 1–20